The ViaCyte Diabetes Trial: Clarifying a Patient Matter
The ViaCyte clinical trial is aimed at producing a “virtual” cure for Type 1 diabetes among children, but the first implantation of the device involved an adult man.
That information was reported by the MIT Technology Reviewand raised a question about whether the article was in error or whether something else was involved.
The California Stem Cell Report …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.